Provided by Tiger Fintech (Singapore) Pte. Ltd.

Medicus Pharma Ltd.

3.29
-0.1500-4.36%
Post-market: 3.290.00000.00%16:54 EDT
Volume:27.84K
Turnover:90.77K
Market Cap:38.58M
PE:- -
High:3.50
Open:3.49
Low:3.16
Close:3.44
Loading ...

Promising Phase 2 Study and Innovative Approach Boost Confidence in Medicus Pharma Ltd.

TIPRANKS
·
16 Feb

Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)

GlobeNewswire
·
14 Feb

Medicus Pharma enters SEPA, intends to voluntarily delist from TSX

TIPRANKS
·
11 Feb

Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)

GlobeNewswire
·
11 Feb

Medicus Pharma Ltd. Announces Change of Auditor

TIPRANKS
·
26 Dec 2024

Medicus Pharma Ltd: Innovative D-MNA Product Positions Company for Success with Favorable Buy Rating

TIPRANKS
·
24 Dec 2024

Medicus Pharma initiated with a Buy at Brookline

TIPRANKS
·
24 Dec 2024

Medicus Pharma Eyes Veterinary Market with FDA Designation

TIPRANKS
·
12 Dec 2024

Medicus Pharma announcs its INAD received MUMS from U.S. FDA

TIPRANKS
·
12 Dec 2024

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

GlobeNewswire
·
12 Dec 2024

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

GlobeNewswire
·
02 Dec 2024

MDCX: Medicus Pharma 3Q 2024 Financial Results Reported; Stock Now Trades Both in Canada and on Nasdaq After Completing an IPO in the U.S.

Zacks Small Cap Research
·
27 Nov 2024

Medicus Pharma Ltd. Expands with Strategic Takeover

TIPRANKS
·
25 Nov 2024

V.MDCX: Medicus Pharma Has Begun Trading on Nasdaq under the ticker MDCX after Completing an IPO in the U.S. The SKNJCT-003 Phase 2 clinical trial continues.

Zacks Small Cap Research
·
25 Nov 2024

Press Release: Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

Dow Jones
·
18 Nov 2024

Medicus Pharma Closes $4M IPO, Trades on Nasdaq

TIPRANKS
·
16 Nov 2024